DUDULIN 2 GENES, EXPRESSION PRODUCTS, NON-HUMAN ANIMAL MODEL: USES IN HUMAN HEMATOLOGICAL DISEASE

Details for Australian Patent Application No. 2003242633 (hide)

Owner INGENIUM PHARMACEUTICALS AG

Inventors GROSSE, Johannes; LAUFS, Jurgen; SCHNEIDER, Boris

Pub. Number AU-A-2003242633

PCT Number PCT/EP03/05920

PCT Pub. Number WO2003/104270

Priority 60/386,302 06.06.02 US

Filing date 5 June 2003

Wipo publication date 22 December 2003

International Classifications

C07K 014/00 Peptides having more than 20 amino acids

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 60/386,302 06.06.02 US

19 February 2004 Application Open to Public Inspection

  Published as AU-A-2003242633

3 March 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003242634-COMPUTER NETWORK LEAKAGE DETECTION, LOCATION AND IDENTIFICATION

2003242632-ELEMENT FOR PACKAGING A BRAKE DISC AND MODULE COMPRISING AT LEAST ONE SUCH ELEMENT